Milestone Pharmaceuticals Inc.

MIST · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$46,685$42,499$45,085$25,314
Short-Term Investments$35,900$918$10,873$44,381
Receivables$1,508$2,003$2,161$2,391
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$86,670$46,168$60,475$73,926
Property Plant & Equip (Net)$1,080$1,249$1,410$1,573
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,080$1,249$1,410$1,573
Other Assets$0$0$0$0
Total Assets$87,750$47,417$61,885$75,499
Liabilities
Payables$3,183$2,928$2,384$1,932
Short-Term Debt$483$515$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,447$3,808$1,159$0
Total Curr. Liab.$10,524$9,283$12,963$8,126
LT Debt$56,206$55,238$54,287$53,352
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$56,725$55,879$55,045$54,226
Other Liabilities$0$0$0$0
Cap. Leases$0$0$1,300$1,445
Total Liabilities$67,249$65,162$68,008$62,352
Equity
Pref Stock$0$0$0$0
Common Stock$311,776$288,263$288,188$288,048
Retained Earnings-$413,194-$401,272-$388,306-$367,545
AOCI$55,649$53,076$53,076$53,076
Other Equity$0$0$0$0
Total Equity$20,501-$17,745-$6,123$13,147
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$87,750$47,417$61,885$75,499
Net Debt$10,004$13,254$9,202$28,038